LSV Asset Management’s Charles River Laboratories CRL Stock Holding History

LSV Asset Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$103M	Sell	455,100 -31,500	-6%	-$5.61M	0.19%	162
2026 Q1	$83.9M	Buy	486,600 +10,700	+2%	+$1.98M	0.18%	174
2025 Q4	$94.9M	Buy	475,900 +178,100	+60%	+$32.3M	0.21%	147
2025 Q3	$46.6M	Buy	297,800 +281,900	+1,773%	+$44.8M	0.1%	214
2025 Q2	$2.41M	Buy	+15,900	New	+$2.12M	0.01%	537
2017 Q4	–	Sell	-26,500	Closed	-$2.86M	–	983
2017 Q3	$2.86M	Hold	26,500	–	–	﹤0.01%	677
2017 Q2	$2.68M	Buy	+26,500	New	+$2.44M	﹤0.01%	679

Other funds holding CRL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

LSV Asset Management's CRL Position: Q2 2026 in Review

LSV Asset Management reduced its Charles River Laboratories (CRL) stake by 6.5% in Q2 2026, selling an estimated $5.61M and leaving 455,100 shares worth $103M. The position accounts for 0.19% of the portfolio, ranked #162.

LSV Asset Management first reported a position in CRL in Q2 2017 and has held it in 7 quarters since. 284 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

LSV Asset Management held 455,100 shares of Charles River Laboratories worth $103M as of Q2 2026.
LSV Asset Management sold 31,500 Charles River Laboratories shares in Q2 2026, an estimated $5.61M.
Charles River Laboratories made up 0.19% of LSV Asset Management's portfolio in Q2 2026, its #162 holding.
LSV Asset Management first reported a position in Charles River Laboratories in Q2 2017 and has held it in 7 quarters since.
284 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on LSV Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.